Tell your dispensing colleagues about

JOIN CDA     NEWS INDEX       POLITICS      DISPENSING      EDUCATION      FEATURES     BOOKS     SMALL ADS     GP FEES    LIGHT BITES

LINKS     FEEDBACK

 


Dispensing Snippets - August 2003

 FREE DISPENSARY VISIT ADVICE SERVICE
New dispensary design?
Increase dispensary efficiency ?  Sell OTCs?
Why pay a non-medical commercial organisation around £1000?
Dr David Roberts (The Complete Dispenser) has over 30 years experience in dispensing practice
For full details
CLICK HERE


BACK TO HEADLINES

 

2 August, 2003
Prison for pharmacist who cheated NHS
Bernard Masters, owner and proprietor of Clifford Evans Ltd, on Ladbroke Grove, Notting Hill, London, was sentenced this week to three years’ imprisonment and ordered to repay £263,000 in compensation.

He had been accused of defrauding the NHS of an estimated £400,000 between 1999 and 2002, by endorsing and amending more than 6,000 prescriptions for financial gain.

Which? on pharmacy
The Consumers’ Association is to publish two new reports on pharmacy. The first, appearing in an autumn edition of Health Which?, plans to survey the public’s perception of existing pharmacy services and poll opinion on access and desirable new services.
This will be followed by a report in Which? This is thought to be another undercover shopper report.e Consumers’ Association is to publish two new reports on pharmacy. The first, appearing in an autumn edition of Health Which?, plans to survey the public’s perception of existing pharmacy services and poll opinion on access and desirable new services.
This will be followed by a report in Which? This is thought to be another undercover shopper report.

AstraZeneca results
AstraZeneca sales for the first half of the year were unchanged despite the loss of £74 million in US sales of Losec,Zestril and Nolvadex. Operating profit for the period declined by 10 per cent.

Sales of anti-cholesterol drug Crestor were £7.3m as it continues to perform well in its first launch markets. On July 9 an advisory committee to the USA Food and Drug Administration voted unanimously to recommend approval for Crestor.

Chief Executive Sir Tom McKillop said:"The successful transformation of our product range is shown by the replacement of US sales of Losec,Zestril and Nolvadex lost to generics by new and high growth products, leaving sales unchanged for the first half."

Pharmacy infections
Community pharmacists could be a useful source of information about the levels of infection, according to a new report from a House of Lords committee.
Fighting Infection says that improvements in infection services, including surveillance, are essential to ensure that England is prepared to prevent and control epidemics.
Committee chairman, Lord Soulsby of Swaffham Prior, said: “The Government must act now to improve services that protect us from infection. We can never conquer infection but we must be better equipped to fight it and to tackle infections like West Nile virus and SARS.
Arrangements for formal collaboration between those involved in the fight against infection are poor and lines of accountability unclear.”